In this episode, we sit down with Amy Abernethy, Principal Deputy Commissioner of the U.S. Food & Drug Administration, for a candid conversation on disruption in healthcare.

We’ll explore how COVID has accelerated change across the system, and whether that disruption is ultimately driving positive transformation for patients, providers, and innovators.